Closed · opens tomorrow 9:30 AM ET
Monday, October 5, 2026· Live edition ·Updated 11:56 PM ET
Drugmakers, biotech, insurers and health policy. 4 stories in the last three days.
Measles Outbreak
Governor Kathy Hochul issued an executive order designating the measles outbreak a state disaster from October 5 through November 4. Officials recorded 108 infections by October 3, including 92 cases in rural regions since mid-July.
HeartBeam
HeartBeam obtained accelerated regulatory status from the Food and Drug Administration for a portable 3D ECG device. The clearance should allow the company to begin clinical testing sooner.
UnitedHealth
State authorities are examining UnitedHealth Group after claims that the insurer blocked necessary care and misled consumers.
Genmab
Genmab reported that Rina-S achieved a 45.9 percent response rate in a phase 2 trial for platinum-resistant ovarian cancer. Patients maintained benefits for an average of 12.1 months while the firm moves the therapy into four late-stage studies.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.